Andreessen Marc L (CIK 1160077) reported 99 SEC Form 4 insider transactions across 8 companies over the past 18 months (most recent 2026-08-11). Recent activity: Buy BRVE (9.1M shares), Buy BRVE (1.1M shares), Sell META (250 shares), Sell META (87 shares), Sell META (44 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Braveheart Bio, Inc. (BRVE) | 10% Owner | Buy | 9.1M | $0 |
| 2026-08-11 | Braveheart Bio, Inc. (BRVE) | 10% Owner | Buy | 1.1M | $19.8M |
| 2026-08-06 | Meta Platforms, Inc. (META) | Director | Sell | 250 | $147,040 |
| 2026-08-06 | Meta Platforms, Inc. (META) | Director | Sell | 87 | $51,264 |
| 2026-08-06 | Meta Platforms, Inc. (META) | Director | Sell | 44 | $25,977 |
| 2026-08-06 | Meta Platforms, Inc. (META) | Director | Sell | 45 | $26,626 |
| 2026-07-29 | Scribe Therapeutics, Inc. (SCTX) | 10% Owner | Buy | 2.1M | $0 |
| 2026-07-29 | Scribe Therapeutics, Inc. (SCTX) | 10% Owner | Buy | 697,650 | $0 |
| 2026-07-29 | Scribe Therapeutics, Inc. (SCTX) | 10% Owner | Buy | 333,333 | $5.0M |
| 2026-07-24 | Samsara Inc. (IOT) | Director | Buy | 7,801 | $0 |
| 2026-06-18 | Coinbase Global, Inc. (COIN) | Director | Buy | 1,150 | $0 |
| 2026-06-12 | Samsara Inc. (IOT) | Director | Sell | 331,194 | $11.3M |
| 2026-06-12 | Samsara Inc. (IOT) | Director | Sell | 168,806 | $5.5M |
| 2026-06-12 | Samsara Inc. (IOT) | Director | Sell | 468,751 | $15.1M |
| 2026-06-12 | Samsara Inc. (IOT) | Director | Sell | 144,909 | $4.7M |
| 2026-06-10 | Samsara Inc. (IOT) | Director | Sell | 531,914 | $18.1M |
| 2026-06-10 | Samsara Inc. (IOT) | Director | Sell | 35,711 | $1.2M |
| 2026-06-10 | Samsara Inc. (IOT) | Director | Sell | 202 | $7,171 |
| 2026-06-10 | Samsara Inc. (IOT) | Director | Sell | 210,126 | $7.0M |
| 2026-06-10 | Samsara Inc. (IOT) | Director | Sell | 190,605 | $6.5M |
| 2026-06-10 | Samsara Inc. (IOT) | Director | Sell | 174,269 | $6.1M |
| 2026-06-04 | Nautilus Biotechnology, Inc. (NAUT) | 10% Owner | Sell | 4.6M | $10.8M |
| 2026-06-04 | Nautilus Biotechnology, Inc. (NAUT) | 10% Owner | Sell | 384,026 | $902,461 |
| 2026-05-19 | Meta Platforms, Inc. (META) | Director | Buy | 480 | $0 |
| 2026-01-09 | Navan, Inc. (NAVN) | Insider | Buy | 46,337 | $839,163 |
Source: SEC Form 4 filings · as of 2026-08-11